Psychostimulants, including amphetamines and methylphenidate, are first-line
pharmacotherapies for individuals with attention-deficit/hyperactivity disorder (ADHD). This …

The adult form of attention-deficit/hyperactivity disorder has a prevalence of up to 5% and is
the most severe long-term outcome of this common disorder. Family studies in clinical …

Attention-deficit/hyperactivity disorder (ADHD) is a common childhood-onset psychiatric
disorder with high heritability. In recent years, numerous molecular genetic studies have …

Attention-deficit/hyperactivity disorder (ADHD) is a common and highly heritable
neurodevelopmental disorder. In recent years, genetic studies have revealed several risk …

The study aimed to explore whether cognitive behavioral therapy (CBT) combined with
medication is superior to CBT alone in core symptoms, emotional symptoms, self-esteem as …

Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder with a
childhood prevalence of 5%. In about two-thirds of the cases, ADHD symptoms persist into …

There is mounting evidence that many highly processed foods have addictive properties,
and that some cases of compulsive overeating resemble an addiction disorder. While …

Objectives: To examine the association of the DNA methylation of DAT1 and DRD4 gene
with methylphenidate (MPH) response in attention deficit hyperactivity disorder (ADHD) …

Background BMP/RA-inducible neural-specific protein 1 (Brinp1) is highly conserved in
vertebrates, and continuously expressed in the neocortex, hippocampus, olfactory bulb and …

Introduction There are limited head-to-head data comparing the efficacy of long-acting
amfetamine-and methylphenidate-based psychostimulants as treatments for individuals with …